ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0.62%
- Poor long term growth as Operating profit has grown by an annual rate 27.23% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
With ROE of 2.48%, it has a Very Expensive valuation with a 2.83 Price to Book Value
- Over the past year, while the stock has generated a return of 316.12%, its profits have risen by 105% ; the PEG ratio of the company is 1.1
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Biocytogen Pharmaceuticals (Beijing) Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
316.12%
8.33
82.97%
Hang Seng Hong Kong
8.25%
0.41
19.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
57.35%
EBIT Growth (5y)
27.23%
EBIT to Interest (avg)
-6.68
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
26.60
Tax Ratio
12.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.08%
ROE (avg)
0.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
114
Industry P/E
Price to Book Value
2.83
EV to EBIT
23.86
EV to EBITDA
10.20
EV to Capital Employed
1.98
EV to Sales
3.07
PEG Ratio
1.08
Dividend Yield
NA
ROCE (Latest)
8.31%
ROE (Latest)
2.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
PRE-TAX PROFIT(Q)
At HKD 52.07 MM has Grown at 210.27%
ROCE(HY)
Highest at 16.13%
NET SALES(Q)
Highest at HKD 667.01 MM
NET PROFIT(Q)
At HKD 30.86 MM has Grown at 150.63%
RAW MATERIAL COST(Y)
Fallen by -3.35% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 2.45 times
DEBTORS TURNOVER RATIO(HY)
Highest at 6.14 times
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Pre-Tax Profit
At HKD 52.07 MM has Grown at 210.27%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Net Sales
Highest at HKD 667.01 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Net Profit
At HKD 30.86 MM has Grown at 150.63%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (HKD MM)
Net Sales
At HKD 667.01 MM has Grown at 49.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Inventory Turnover Ratio
Highest at 2.45 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 6.14 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -3.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
